Two additive mechanisms impair the differentiation of 'substrate-selective' p38 inhibitors from classical p38 inhibitors in vitro

por Hendriks, Bart S, Seidl, Kelly M, Chabot, Jeffrey R
Publicado 2010

Population pharmacokinetics of ATR inhibitor berzosertib in phase I studies for different cancer types

por Terranova, Nadia, Jansen, Mendel, Falk, Martin, Hendriks, Bart S.
Publicado 2020

Whole-body organ-level and kidney micro-dosimetric evaluations of (64)Cu-loaded HER2/ErbB2-targeted liposomal doxorubicin ((64)Cu-MM-302) in rodents and primates

por Gaddy, Daniel F, Lee, Helen, Zheng, Jinzi, Jaffray, David A, Wickham, Thomas J, Hendriks, Bart S
Publicado 2015

Using local clinical and microbiological data to develop an institution specific carbapenem-sparing strategy in sepsis: a nested case-control study

por Lambregts, Merel M. C., Hendriks, Bart J. C., Visser, Leo G., Bernards, Sandra T., de Boer, Mark G. J.
Publicado 2019

Liposomal (64)Cu-PET Imaging of Anti-VEGF Drug Effects on Liposomal Delivery to Colon Cancer Xenografts

por Blocker, Stephanie J., Douglas, Kirk A., Polin, Lisa Anne, Lee, Helen, Hendriks, Bart S., Lalo, Enxhi, Chen, Wei, Shields, Anthony F.
Publicado 2017

Companion Diagnostic (64)Cu-Liposome Positron Emission Tomography Enables Characterization of Drug Delivery to Tumors and Predicts Response to Cancer Nanomedicines

por Lee, Helen, Gaddy, Daniel, Ventura, Manuela, Bernards, Nicholas, de Souza, Raquel, Kirpotin, Dmitri, Wickham, Thomas, Fitzgerald, Jonathan, Zheng, Jinzi, Hendriks, Bart S.
Publicado 2018

Longitudinal PET Imaging to Monitor Treatment Efficacy by Liposomal Irinotecan in Orthotopic Patient-Derived Pancreatic Tumor Models of High and Low Hypoxia

por Ventura, Manuela, Bernards, Nicholas, De Souza, Raquel, Fricke, Inga B., Hendriks, Bart S., Fitzgerald, Jonathan B., Lee, Helen, Klinz, Stephan G., Zheng, Jinzi
Publicado 2019

Phase 1 study of the ATR inhibitor berzosertib in combination with cisplatin in patients with advanced solid tumours

por Shapiro, Geoffrey I., Wesolowski, Robert, Devoe, Craig, Lord, Simon, Pollard, John, Hendriks, Bart S., Falk, Martin, Diaz-Padilla, Ivan, Plummer, Ruth, Yap, Timothy A.
Publicado 2021

Phase 1 study of the ATR inhibitor berzosertib (formerly M6620, VX-970) combined with gemcitabine ± cisplatin in patients with advanced solid tumours

por Middleton, Mark R., Dean, Emma, Evans, Thomas R. J., Shapiro, Geoffrey I., Pollard, John, Hendriks, Bart S., Falk, Martin, Diaz-Padilla, Ivan, Plummer, Ruth
Publicado 2021

Cues to improve antibiotic-allergy registration: A mixed-method study

por Sijbom, Martijn, Braun, Karolina K., Büchner, Frederike L., van Bodegom-Vos, Leti, Hendriks, Bart J. C., de Boer, Mark G. J., Numans, Mattijs E., Lambregts, Merel M. C.
Publicado 2022

Outpatient parenteral antifungal therapy (OPAT) for invasive fungal infections with intermittent dosing of liposomal amphotericin B

por van de Peppel, Robert J, Schauwvlieghe, Alexander, Van Daele, Ruth, Spriet, Isabel, van't Wout, Jan W, Brüggemann, Roger J, Rijnders, Bart J A, Hendriks, Bart J C, de Boer, Mark G J
Publicado 2020

Safety and pharmacokinetics of MM-302, a HER2-targeted antibody–liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation st...

por Munster, Pamela, Krop, Ian E., LoRusso, Patricia, Ma, Cynthia, Siegel, Barry A., Shields, Anthony F., Molnár, István, Wickham, Thomas J., Reynolds, Joseph, Campbell, Karen, Hendriks, Bart S., Adiwijaya, Bambang S., Geretti, Elena, Moyo, Victor, Miller, Kathy D.
Publicado 2018

Implementation of a clinical decision rule for selecting empiric treatment for invasive aspergillosis in a setting with high triazole resistance

por van de Peppel, Robert J, van Grootveld, Rebecca, Hendriks, Bart J C, van Paassen, Judith, Bernards, Sandra, Jolink, Hetty, Koopmans, Julia G, von dem Borne, Peter A, van der Beek, Martha T, de Boer, Mark G J
Publicado 2021